A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

NCT03661138 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

272

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Upadacitinib
DRUG: Placebo for upadacitinib
DRUG: Topical Corticosteroids (TCS)

Sponsor

AbbVie